PT-141 (Bremelanotide) – 10mg

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide and melanocortin-receptor agonist. Structurally a metabolite of the melanocortin peptide Melanotan-2, PT-141 is studied in preclinical research for its activity at the melanocortin receptors, notably MC3R and MC4R, within the central melanocortin system.

PT-141 is a frequent subject of in-vitro and animal research into melanocortin-receptor signaling, central-nervous-system pathways, and comparative melanocortin pharmacology. Supplied as a research-grade lyophilized powder for laboratory use only.

Key Research Highlights

• Synthetic cyclic heptapeptide melanocortin-receptor agonist
• Studied for activity at the MC3R and MC4R melanocortin receptors
• Structurally related to Melanotan-2 and used in comparative melanocortin research
• Investigated in research on the central melanocortin system and receptor signaling
• A subject of receptor-binding and neuropharmacology preclinical research

Related research: Melanotan-2 melanocortin research.

Product Specifications

• Form: Lyophilized powder
• Content: 10 mg
• Purity: ≥98% (HPLC tested); identity confirmed by mass spectrometry
• Storage: Store lyophilized at -20°C. After reconstitution, refrigerate (2-8°C) and use within approximately 28 days.
• For Research Use Only. Not for human consumption.

Why Choose Rejuven8 Peptides for PT-141?

• Third-party tested for purity and identity, with a lot-specific Certificate of Analysis
• Fast, discreet U.S. shipping
• Trusted by neuroscience and peptide-pharmacology researchers